BiotechTube
Home/HebeCell/John Lu, Ph.D, MPH
JL

John Lu, Ph.D, MPH

President and CEO

HebeCell

Therapeutic Areas

OncologyRegenerative Medicine

HebeCell Pipeline

DrugIndicationPhase
PSC-derived NK CellsCancer (unspecified)Pre-clinical
Retinal Photoreceptor Progenitors (RPRPs)Degenerative Retinal DiseaseResearch

Leadership Team at HebeCell

AF
Allen Feng, Ph.D
Chief Scientific Officer
View full HebeCell profile